Ultragenyx Pharmaceutical Stock Forecast

Sell candidate since Jul 29, 2026 Loss -0.36%

The Ultragenyx Pharmaceutical Inc. stock price fell by -4.34% on the last day (Friday, 31st Jul 2026) from $26.04 to $24.91. During the last trading day the stock fluctuated 6.00% from a day low at $24.60 to a day high of $26.08. The price has fallen in 8 of the last 10 days and is down by -14.92% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -52 thousand shares and in total, 2 million shares were bought and sold for approximately $38.30 million.

Given the current short-term trend, the stock is expected to rise 21.83% during the next 3 months and, with a 90% probability hold a price between $30.35 and $46.14 at the end of this 3-month period.

RARE Signals & Forecast

There are few to no technical positive signals at the moment. The Ultragenyx Pharmaceutical Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $26.11 and $29.33. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -30.55%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Ultragenyx Pharmaceutical Inc. stock

Ultragenyx Pharmaceutical Inc. finds support from accumulated volume at $24.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.48 between high and low, or 6.00%. For the last week, the stock has had daily average volatility of 6.05%.

Ultragenyx Pharmaceutical Inc. is oversold on RSI14 (11). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RARE) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Ultragenyx Pharmaceutical Inc. to open at $25.20, and during the day (based on 14 day Average True Range), to move between $24.17 and $25.65, which gives a possible trading interval of +/-$1.49 (+/-6.15%) up or down from last closing price. If Ultragenyx Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 6.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $24.85 (0.24%) than the resistance at $25.00 (0.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ultragenyx Pharmaceutical Inc. stock A Buy?

The Ultragenyx Pharmaceutical Inc. stock holds several negative signals and despite the positive trend, we believe Ultragenyx Pharmaceutical Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.027 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $25.20 ( 1.14%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk